What is Aquestive Therapeutics, Inc.'s debt repayments?

Aquestive Therapeutics, Inc. (AQST) reported debt repayments of $8K in Q1 2026.

How has Aquestive Therapeutics, Inc.'s debt repayments changed year-over-year?

Aquestive Therapeutics, Inc.'s debt repayments increased by 33.3% year-over-year, from $6K to $8K.

Aquestive Therapeutics, Inc. AQST Debt Repayments

Debt Repayments at other companies

Zevra Therapeutics, Inc.ZVRA

——

Other financials

Income statement

See full

Revenue$14.4M+65.7%

Gross profit$11.0M+117%

Operating income-$4.2M+78.3%

Net income-$8.1M+64.9%

EPS (diluted)-$0.07+70.8%

Balance sheet

See full

Cash & equivalents$110.7M+61.3%

Total debt$64.4M+7.4%

Total equity-$34.1M+44.1%

Total assets$141.1M+38.0%

Cash flow

See full

Operating cash flow-$14.8M+36.7%

CapEx$52.0K-61.5%

Free cash flow-$14.9M+36.9%

Valuation

See full

Market cap$560.13M+73.5%

Enterprise value$513.76M+63.6%

P/S11.1×+5.2×

Profitability

See full

Gross margin63.5%-4.9pp

Operating margin-111.2%+96.3pp

Net margin-137.1%+80.7pp

FCF margin-88.2%-2.2pp

Returns & leverage

See full

Return on equity145.1%—

Debt / equity-1.9×—

Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfDebt.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s debt repayments?: Aquestive Therapeutics, Inc. (AQST) reported debt repayments of $8K in Q1 2026.
How has Aquestive Therapeutics, Inc.'s debt repayments changed year-over-year?: Aquestive Therapeutics, Inc.'s debt repayments increased by 33.3% year-over-year, from $6K to $8K.